TAURAS - T790 AURA ScreenFailure SOC Registry Study

TerminatedOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Non Small Cell Lung Cancer
Interventions
OTHER

Patient Reported Outcome (PRO)

Exposure to Quality of Life Questionnaires (EORTC QLQ-LC13, EORTC QLQ-C30 and EQ-5D-5L) every 3 months during standard of care visits.

Trial Locations (5)

Unknown

Research Site, Oceanside

Research Site, Santa Rosa

Research Site, Seongnam

Research Site, JinJoo

Research Site, Ulsan

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Parexel

INDUSTRY

lead

AstraZeneca

INDUSTRY